Quadriplegia Treatment Market Size & Share, by Treatment Type (Corticosteroids, Non-Steroidal Anti-inflammatory Drugs, Antidepressants, Anticonvulsants, Narcotic Analgesics, Antispasmodics & Muscle Relaxants); Route of Administration (Oral, Intravenous); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Stores) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 3951
  • Published Date: Jan 12, 2024
  • Report Format: PDF, PPT

Companies Dominating the Quadriplegia Treatment Market

top-features-companies
    • Sanofi SA
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • AstraZeneca plc
    • GlaxoSmithKline plc
    • Johnson & Johnson Services, Inc.
    • Bristol Myers Squibb Company
    • Eli Lily & Company
    • Teva Pharmaceuticals, Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • A group of scientists, medical professionals, and researchers led by Battelle and The Ohio State University Wexner Medical Centre have shown for the first time that a person with a clinically complete spinal cord injury (SCI) can use a brain-computer interface (BCI) to simultaneously reanimate both motor function and sense of touch to improve quality of life and assist individuals in being more entire once again and less reliant on caregivers.
  • A team of Johns Hopkins neurosurgeons and biomedical engineers developed implantable ultrasound technology and other devices to completely change the way spinal cord injury patients are treated and to assist medical professionals in observing and managing the changes in blood flow and avoiding tissue death that happens right away after a spinal cord accident.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3951
  • Published Date: Jan 12, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The increasing incidence of spinal cord injuries across the world and the growing advancement in the field of quadriplegia treatment are the major factors driving the growth of the market.

The market size of quadriplegia treatment is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2024-2036.

The major players in the market are Sanofi SA, AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Bristol Myers Squibb Company, and others.

The hospital pharmacies segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying